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element insertions that alter its structure
David Valle-García1,2†, Lyra M Griffiths3†, Michael A Dyer3,4*, Emily Bernstein2* and Félix Recillas-Targa1*Abstract
The SWI/SNF-like chromatin-remodeling protein ATRX has emerged as a key factor in the regulation of α-globin gene
expression, incorporation of histone variants into the chromatin template and, more recently, as a frequently mutated
gene across a wide spectrum of cancers. Therefore, the availability of a functional ATRX cDNA for expression studies is
a valuable tool for the scientific community. We have identified two independent transposon insertions of a bacterial
IS10 element into exon 8 of ATRX isoform 2 coding sequence in two different plasmids derived from a single source.
We demonstrate that these insertion events are common and there is an insertion hotspot within the ATRX cDNA. Such
IS10 insertions produce a truncated form of ATRX, which significantly compromises its nuclear localization. In turn, we
describe ways to prevent IS10 insertion during propagation and cloning of ATRX-containing vectors, including optimal
growth conditions, bacterial strains, and suggested sequencing strategies. Finally, we have generated an insertion-free
plasmid that is available to the community for expression studies of ATRX.
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ATRX is an ATP-dependent chromatin-remodeling heli-
case of the SWI/SNF family and was originally identified
because mutations in its coding region give rise to a com-
plex disorder known as α-Thalassemia, Mental Retardation
X-linked (ATRX) syndrome. Its role in the α-Thalassemia
feature of this syndrome is through its regulation of the
chromatin state of the α-globin genes (Higgs et al.
2005; Gibbons 2006; Law et al. 2010; Ratnakumar et al.
2012). However, its role in other ATRX syndrome traits
remains largely unknown. Mechanistically, ATRX has
been implicated in heterochromatin maintenance and
formation, DNA methylation, regulation of gene expres-
sion, alternative lengthening of telomere suppression and
histone variant deposition (for review see: Bérubé 2011;
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reproduction in any medium, provided the origRecently, large-scale genome sequencing efforts have
identified ATRX mutations and deletions in a range of
tumor types, including glioblastoma multiforme, neuro-
blastoma and pancreatic neuroendocrine tumors (Jiao
et al. 2011; Schwartzentruber et al. 2012; Cheung et al.
2012; Molenaar et al. 2012; Clynes et al. 2013). These
alterations appear to result in loss of functional ATRX,
suggesting that ATRX acts as tumor suppressor. How-
ever, the mechanisms by which such mutations result
in ATRX loss-of-function remain unclear.
For the reasons noted above, ATRX has emerged as an
important chromatin remodeler to study during normal
development and disease. However, the cloning and
overexpression of ATRX cDNA has been challenging due
to its large size: 2,492 amino acids encoded in an 11,167
bp cDNA (isoform 1) and 2,454 amino acids encoded in
an 11,031 bp cDNA (isoform 2). Here, we report two
independent transposon insertions of an IS10 element
into exon 8 of the ATRX isoform 2 coding sequence in
two different plasmids derived from a single original
source. Our data suggest that ATRX contains at least one
insertion hot spot that is highly active when the plasmid is
grown under standard bacterial conditions. Therefore,
we recommend strategies to prevent IS10 insertions
during propagation and cloning of ATRX-containingis is an Open Access article distributed under the terms of the Creative
mmons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
inal work is properly credited.
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this insertion and conclude that IS10 insertions produce
a truncated form of ATRX that compromises its cellular
distribution.
Results and discussion
We sequenced two different ATRX plasmids that have been
widely used for overexpression experiments (Additional
file 1) (Bérubé et al. 2002, 2008; McFarlane and Preston
2011; Ratnakumar et al. 2012; Newhart et al. 2012). One of
the plasmids contains the full length ATRX cDNA sequence
in a pEGFP (GFP-ATRX) (Bérubé et al. 2008) backbone
and the other is cloned in a lentiviral backbone (ATRX-
YFP) and was derived from the sequence contained in
GFP-ATRX (Newhart et al. 2012). We found that the ATRX
cDNA sequence that has been cloned corresponds to
isoform 2, which lacks exon 6 in comparison to isoform
1. Exon 6 codes for 38 highly conserved amino acids.
The functional relevance, if any, between isoform 1 and
isoform 2 has yet to be reported. In addition, we found
that E124 is missing in ATRX isoform 2. This amino
acid is the last residue encoded by exon 5.
To our surprise, we uncovered transposon insertions
of IS10 elements within the ATRX coding sequence in
both plasmids analyzed (Figure 1A-B). The transposable
prokaryotic IS family has been reported to be a common
source of mutations in the Escherichia coli genome
(Rodriguez et al. 1992). Likewise, it has also been shown
that IS10-related sequences may lead to cloning aberra-
tions and sequence contamination of plasmids hosted in
E. coli (Rood et al. 1980; Müller et al. 1989; Kovarík
et al. 2001; Kobori et al. 2009; Umenhoffer et al. 2010).
Interestingly, the IS10 insertion in both plasmids - which
we name IS10-GFP-ATRX and IS10-ATRX-YFP - was
found in exon 8. However, sequencing and PCR analyses
showed that both the insertion site and the direction of
the IS10 element are different in each plasmid, suggesting
independent insertion events (Figure 1A,B, Additional
file 1). The insertion site within IS10-GFP-ATRX closely
resembles the 9-bp canonical IS10 insertion sequence
(Additional file 1, see Kovarík et al. 2001), and may repre-
sent a hotspot for IS10 transposition. The insertion site
within IS10-ATRX-YFP has a more divergent sequence. It
is interesting to note that IS10-ATRX-YFP was derived
from IS10-GFP-ATRX, however there is no sequence
evidence of an IS10 excision in IS10-ATRX-YFP. This
suggests that the ATRX cDNA of IS10-GFP-ATRX used
to derive IS10-ATRX-YFP was lacking the IS10 inser-
tion, and that the insertion observed in the latter was
acquired during the cloning or plasmid expansion
process. This highlights the dynamic feature of this
transposable element.
In order to assess if the expression of the truncated form
of ATRX derived from the IS10-GFP-ATRX plasmid mayretain some of the characteristics of full length ATRX,
we sub-cloned the ATRX cDNA sequence from the
IS10-GFP-ATRX plasmid to generate an ‘Insertion-Free’
vector that we call IF-GFP-ATRX (see details in Methods).
IF-GFP-ATRX was further analyzed by PCR and restric-
tion analysis (data not shown) and the ATRX cDNA
was fully sequenced to ensure that the insertion was
completely removed (Additional file 1).
Next we investigated if the insertions are an isolated
event or a common phenomenon. IF-GFP-ATRX was
transformed into both DH5α and Stbl4 E. coli strains.
The plasmids were analyzed by colony PCR with primers
spanning the IS10 insertion sites found in IS10-ATRX-
YFP and IS10-GFP-ATRX (Additional file 1, see Methods).
We found that 18% of the DH5α colonies (26 out of 139
analyzed colonies) present evidence of insertions within
exon 8. Sequencing and restriction analysis of the plasmid
containing insertions revealed that the observed change is
caused by de novo insertions of the IS10 transposable
element (Figure 1C, Additional file 1). Conversely, the
plasmid derived from the Stbl4 bacteria - a strain spe-
cifically designed for cloning unstable inserts - showed
a significant lower insertion rate (3 out of 80 analyzed
colonies – p-value < 0.01, binomial test). Furthermore,
we found evidence of other aberrations in the DH5α
colonies by restriction analyses (6 out of 30 analyzed
colonies that did not contain the exon 8 IS10 insertion;
data not shown). This suggests that the ATRX plasmid
may be subjected to IS10 insertions in other regions of
the ATRX cDNA or other types of alterations such as
recombination events. This data strongly suggests that
insertions within the ATRX coding sequence in E. coli are
a common event that is influenced by the bacterial strain
used to amplify ATRX-containing plasmids. Moreover, our
results suggest that ATRX presents an IS10 insertion hot-
spot within exon 8. The causes that trigger the insertion of
the IS10 element within the ATRX cDNA remain unclear.
However, the homogeneity of the restriction patterns in
the IF-GFP-ATRX with de novo IS10 insertions (Figure 1C)
suggests that the IS10 transposition is an early clonal
event. In fact, it has been proposed that the stress induced
by the transformation process may be a trigger for IS10
transposition (Kovarík et al. 2001).
We next transfected IS10-GFP-ATRX and IF-GFP-
ATRX into HEK 293T cells and assessed ATRX expression
and chromatin association. We found that the transfection
efficiency was approximately double for IS10-GFP-ATRX
(60%) compared to IF-GFP-ATRX (30%), and that the
sub-cellular localization was dramatically different (data
not shown, Figure 2A). As expected, IF-GFP-ATRX trans-
fected cells show a focal nuclear localization of GFP-ATRX
(Figure 2A) in agreement with previous reports (Xue et al.
2003; Tang et al. 2004; Ishov et al. 2004; Bérubé et al. 2008).
However, we observed a clear cytoplasmic GFP signal in
Figure 1 ATRX overexpression plasmids contain IS10 insertions. (A) Schematic map of the insertions found in IS10-GFP-ATRX and IS10-ATRX-
YFP. The exon structure (alternate white and gray bars) of ATRX cDNA isoform 2 (top) and some relevant domains from the protein sequence (bottom)
are shown. The insertion sites are denoted by black bars and their positions in the cDNA and the protein are described in the right box. Black arrows
show the direction of the IS10 elements found. The stop codons introduced by IS10 in the protein sequence are indicated with asterisks. The position
of two of the primer pairs used for analyzing ATRX sequence is shown (white and gray arrows). The NLS within ATRX cDNA is indicated with a black
bar. (B) PCR analysis of IS10-GFP-ATRX, IS10-ATRX-YFP and IF-GFP-ATRX using the primers shown in (A). Both amplicons of IF-GFP-ATRX have
the expected size (1,449 bp for amplicon I and 1,935 for amplicon II) while amplicon I shows an insertion in IS10-ATRX-YFP and amplicon II
shows an insertion in IS10-GFP-ATRX (both have additional 1,336 bp). (C) Representative EcoRI digestion patterns of the IF-GFP-ATRX plasmid
grown in two different bacteria strains. The Stbl4-derived plasmid has the expected pattern while the plasmid derived from DH5α shows an
insertion in the 2,400bp fragment (shift from a 2,468 bp fragment to ~3,800 bp).
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nuclear localization (Figure 2A). According to our sequence
analysis, a stop codon is introduced right after the IS10
insertion site in both plasmids containing the IS10 element
(Figure 1A). As ATRX is N-terminally GFP-tagged, the
fluorescence observed in the IS10-GFP-ATRX transfec-
tants is likely due to the overexpression of a truncated
GFP-ATRX fusion that contains only the ADD domain
(Figure 1A).
Although we cannot exclude the possibility that the
re-localization of the IS10-GFP-ATRX is due to an over-
expression effect, ATRX nuclear localization is dependent
on nuclear localization sequences (NLS) (Bérubé et al.
2008) and our sequence analysis predicts that the IS10-
GFP-ATRX lacks the NLS (Figure1A). However, we
note that although ATRX cytoplasmic localization is
clear in the IS10-GFP-ATRX transfected cells, cells still
do show some nuclear localization (Figure 2A). Because
the ADD domain alone is capable of recognizing and
binding the histone H3 tail in vitro by reading the com-
binatorial methylation state of histone H3 lysines 4 and
9 (Eustermann et al. 2011; Iwase et al. 2011) a small
fraction of the expressed protein product may still be
tethered to chromatin.To probe this further and assay the chromatin associ-
ation of the ATRX protein products, we prepared both
whole cell and chromatin extracts from the transfected
HEK 293T cells and performed Western blot analyses. As
predicted, we found a truncated ATRX product from
the transfections performed with the IS10-GFP-ATRX
plasmid (Figure 2B,C). This truncated product is ~70
kDa and corresponds to the ATRX ADD domain coupled
to the N-terminal GFP. This is further supported by the
fact that the IS10-GFP-ATRX product is detectable only
with a GFP antibody and not with an ATRX antibody
whose epitope recognizes the C-terminal portion of the
protein (data not shown).
While we observed chromatin-bound full-length ATRX
from the IF-GFP-ATRX transfections, we noted that
the IS10-GFP-ATRX truncated product also binds to
the chromatin fraction (Figure 2C). This supports the
idea that the ADD domain allows binding to chromatin.
Whether the IS10-GFP-ATRX product has any effect
on the chromatin landscape remains to be explored, for
example, it could act as a dominant negative. However, it
is interesting to note that in comparison to full-length
ATRX, the IS10-GFP-ATRX fragment has a greater
accumulation in whole cell extracts (Figure 2B) than
Figure 2 IS10-element alters GFP-ATRX localization and incorporation into chromatin. (A) HEK-293T cells were transiently transfected with
IS10-GFP-ATRX (left) or IF-GFP-ATRX (right). The localization of GFP-ATRX was determined by confocal fluorescence microscopy 72 hours post-transfection.
Representative images are shown. Dashed lines on the highlighted cells indicate nuclei area. IS10-GFP-ATRX displays a diffuse nuclear and cytoplasmic
localization. Conversely, ATRX-GFP has a nuclear localization in the IF-GFP-ATRX transfected cells with a focal pattern. (B) Western analysis of whole cell
protein extracts from the IS10-GFP-ATRX and IF-GFP-ATRX transfections against GFP (top) and actin (bottom). Bands corresponding to IF-GFP-ATRX and
IS10-GFP-ATRX products are indicated with arrows. (C) Chromatin extracts from the IS10-GFP-ATRX and IF-GFP-ATRX transfections were analyzed with
GFP antibodies (top). Bands corresponding to IF-GFP-ATRX and IS10-GFP-ATRX products are highlighted with arrows. Amido black staining of histones
was used as a loading control (bottom). A truncated product is observed in the IS10-GFP-ATRX transfections.
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strongly suggest that the IS10 element provokes the
production of a truncated ATRX form that has a diffuse
cellular localization, but still retains the capacity to bind to
chromatin. Importantly, during experimental conditions, if
one were to perform immunofluorescence of IS10-GFP-
ATRX transduced cells without Western blot analysis, one
might conclude that full length ATRX is expressed.
Conclusions
Here we show that two ATRX overexpression plasmids,
utilized in the ATRX research community, contain IS10-
element insertions around a probable hot spot in exon 8
of ATRX. Further, we demonstrate that IS10 transposition
events are common if ATRX-containing vectors are grown
in standard bacteria strains. We note here that the
dynamic nature of the insertions makes it likely that
any single lab may have batches of contaminated andinsertion-free plasmid. We further highlight that the
published studies of ATRX function using these plasmids
may have indeed been insertion-free, as we have confirmed
for our own studies (Ratnakumar et al. 2012). However,
because the IS10-element has a significant effect on ATRX
sub-cellular localization and allows its incorporation
into chromatin, experiments performed with IS10-
ATRX-containing plasmids could generate inaccurate
conclusions.
It has not escaped our attention that despite all the
mutations identified in ATRX syndrome patients and,
more recently, in distinct cancer types (Jiao et al. 2011;
Schwartzentruber et al. 2012; Cheung et al. 2012; Clynes
et al. 2013), few ATRX over-expression experiments
mimicking such mutations have been published. It is our
belief that to understand the contribution of ATRX
mutations in disease etiology, we need to develop reliable
over-expression systems. However, our results show that
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nical hurdles that the community should be aware of.
Finally, we have made our IF-GFP-ATRX plasmid avail-
able through the AddGene database (plasmid 45444).
Also, we provide technical advice for the propagation
and cloning of ATRX-containing vectors (see Methods
section). The sequences obtained from the IS10-GFP-
ATRX and IS10-ATRX-YFP plasmids, as well as the
primers used for the ATRX sequencing, cloning and
analysis are included in the Additional file 1. Thus, we
recommend that each laboratory should take the necessary
steps to avoid IS10 contamination and test each plasmid
preparation for IS10 insertion elements. We are hopeful
that this technical resource will be useful for future
studies and will help to avoid propagation and usage of
IS10-ATRX-containing plasmids.
Methods
ATRX-containing plasmid propagation and handling
The ATRX plasmids were propagated using ElectroMAX™
Stbl4™ Competent Cells (Life Technologies, 11635-018).
Top10 (Invitrogen, C404003) and DH5α bacteria were
also used and are not recommended for growing ATRX-
containing plasmids. We recommend growing bacteria at
30°C to avoid plasmid recombination. Using strains lack-
ing IS-elements such as MDS42 is also recommended.
ATRX PCR analysis and sequencing
PCR analyses were performed using Platinum® Pfx DNA
Polymerase (Invitrogen 11708-013), according to manufac-
turer’s indications. The primers used span across the ATRX
cDNA and their sequences can be found in Additional
file 1. ATRX cDNA sequencing was performed using the
same primers and one additional primer specific for
exon 8 that can also be found in Additional file 1. We
recommend analyzing the plasmid by PCR (or restriction
digest) following culture in E. coli and on a frequent basis
when working with ATRX-containing vectors.
ATRX transformation and growth in different
bacterial strains
ElectroMAX™ Stbl4™ competent cells (Life Technologies,
11635-018) and DH5α competent cells (Life Technologies
18258-012) were transformed according to manufacturer’s
indications with 50 ng of IF-GFP-ATRX. Cells were plated
and growth at 37°C. Colonies from three independent
transfections were picked and diluted in 100μl of PBS. 5 μl
were used for colony PCR using the ATRX IS10 primers
from Additional file 1. Colonies that presented evidence of
insertion, as well as control colonies were minipreped
using the QIAprep Spin Miniprep Kit (Qiagen, 27106) 2
μg of the plasmid were digested with 2 units of EcoRI
(New England Biolabs, R0101S) for 1 hour at 37°C.IF-GFP-ATRX construct generation
IS10-GFP-ATRX was digested with BamHI and AflII (NEB)
to produce a 1200 bp band (Fragment A). A plasmid











digestion product was generated using the GenScript
plasmid and enzymes, AflII and AgeI (Fragment B). A
restriction digestion product of IS10-GFP-ATRX was
generated using enzymes, AgeI (NEB) and XbaI (Fragment
C). Finally, BamHI and XbaI (NEB) were used to digest
pEGFP-C2 plasmid, generating a backbone for insertion
of the ATRX fragments. The three ATRX-containing
fragments (A, B, and C) were ligated first (1200 bp +
300 bp + 6000 bp). Then the backbone pEGFP vector was
added for a second ligation reaction. Ligation product
was transformed into dam-/dcm- competent E. coli (NEB
C2925H). Colonies were mini-prepped and sequenced.Transfections
Transfections were performed in the HEK-293T cell line
(ATCC: CRL-11268) using Lipofectamine® 2000 transfec-
tion reagent according to manufacturer’s indications. 14 μg
of each plasmid were transfected in 70% confluent 10 cm
plates. Cells were harvested 48 hours post-transfection for
chromatin preparation or fixed for microscopy (see below).Microscopy
24 hours post-transfection, cells were seeded onto chamber
well slides. 48 hours later, cells were fixed with 4% parafor-
maldehyde/PBS (Sigma Aldrich) at 4°C overnight. Slides
were stained with 4′,6-diamidino-2-phenylindole (DAPI)
for 10 minutes at room temperature. Images were collected
with a Zeiss LSM700 confocal microscope.Chromatin isolation and western analysis
Chromatin isolation was performed as described previ-
ously (Méndez and Stillman 2000) and chromatin samples
were boiled at 100°C for 10 minutes instead of being soni-
cated. Western analysis was performed with the following
antibodies: GFP (Santa Cruz sc-8334, 1:200 or Roche
1181460001, 1:10,000), Actin (Sigma-Aldrich A1978, 0.75
μg/mL). Histones from chromatin extracts were stained
with amido black staining solution (Sigma A8181-1EA).
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Additional file 1: Plasmid and primer sequences. This files contains
the sequences of the IS10 insertions, all the primers used for the analyses
described on the paper, and the full IF-GP-ATRX sequence.
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